Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Journal of Personalized Medicine|April 30, 2021
A Novel Low-Risk Germline Variant in the SH2 Domain of the SRC Gene Affects Multiple Pathways in Familial Colorectal CancerDiamanto Skopelitou, Beiping Miao, Aayushi Srivastava, et al.Frontiers in Bioengineering and Biotechnology|March 27, 2020
Identification of Familial Hodgkin Lymphoma Predisposing Genes Using Whole Genome SequencingAayushi Srivastava, Sara Giangiobbe, Abhishek Kumar, et al.International Journal of Molecular Sciences|March 6, 2021
Whole Exome Sequencing Identifies <i>APCDD1</i> and <i>HDAC5</i> Genes as Potentially Cancer Predisposing in Familial Colorectal CancerDiamanto Skopelitou, Beiping Miao, Aayushi Srivastava, et al.Cancers|July 2, 2021
Elevated Expression of the <i>RAGE</i> Variant-<i>V</i> in SCLC Mitigates the Effect of Chemotherapeutic DrugsBindhu K Madhavan, Zhe Han, Bishal Singh, et al.The EMBO Journal|April 28, 2020
Compromised DNA repair is responsible for diabetes-associated fibrosisVarun Kumar, Raman Agrawal, Aparamita Pandey, et al.International Journal of Cancer|August 5, 2005
Global analysis of host tissue gene expression in the invasive front of colorectal liver metastasesObul Reddy Bandapalli, Martina Geheeb, Dennis Kobelt, et al.International Journal of Molecular Sciences|February 15, 2022
Whole-Exome Sequencing Identifies a Novel Germline Variant in <i>PTK7</i> Gene in Familial Colorectal CancerBeiping Miao, Diamanto Skopelitou, Aayushi Srivastava, et al.Cancers|February 15, 2022
Germline Variants of <i>CYBA</i> and <i>TRPM4</i> Predispose to Familial Colorectal CancerLizhen Zhu, Beiping Miao, Dagmara Dymerska, et al.Cancer Research|September 19, 2007
Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signalingCharlotte Kopitz, Michael Gerg, Obul Reddy Bandapalli, et al.Aging|November 8, 2015
A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34+ hematopoietic stem cells not reversible by mTOR-inhibitionClemens Stockklausner, Simon Raffel, Julia Klermund, et al.Pageof 4